Upcoming NCI U24: ETCTN Pharmacokinetics Resource Laboratory for early-phase cancer trials
NCI plans to issue a NOFO in Summer 2025 for a U24 award to operate a Pharmacokinetics Resource Laboratory supporting ETCTN early-phase cancer trials of NCI IND agents. The lab will handle biospecimen collection and deliver PK/PD analyses, drug–drug and CYP interaction studies, and reporting through technical services, scientific leadership, and biospecimen cores. Applications are not yet bein…
The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) solicits applications from institutions/organizations that propose to maintain or establish a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the Experimental Therapeutics Clinical Trial…
Funding Source
Awards & funding
Eligibility
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers